{
  "ptid_time": "005_S_1341_2007-03-07",
  "img_path": "/data/qiuhui/data/adni/images/005_S_1341/2007-03-07/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 32,530 mm³, 15.9% above the reference mean. With a Z-score of 0.36 (64.2th percentile), this represents normal volume ; whole brain volume measures 832,358 mm³, 14.6% below the reference mean. With a Z-score of -1.84 (3.3th percentile), this represents moderate atrophy. ",
  "text_data": "Age is 71.6 years. Gender is Female. Education: 12 years. Handedness: Right. Race: White. Medical history: Psychiatric; Head, Eyes, Ears, Nose and Throat; Cardiovascular; Respiratory; Dermatologic-Connective Tissue; Musculoskeletal; Renal-Genitourinary; Allergies or Drug Sensitivities; Major Surgical Procedures. MMSE: 24.0. Logical Memory: 0.0. APOEε4 alleles: 1.0. Biomarker levels: Amyloid beta: 507.10 pg/mL (mild reduced); Total tau: 377.40 pg/mL (moderate elevated); Phosphorylated tau: 33.26 pg/mL (moderate elevated). ",
  "true_diagnosis": "Diagnosis: AD.",
  "gpt_diagnosis": "**Reasoning:** The patient shows moderate whole brain atrophy (Z-score -1.84, 3.3rd percentile) with normal ventricular volume, suggesting neurodegeneration. Combined with mild Aβ reduction and moderate tau elevation (consistent with Alzheimer’s pathology), as well as an MMSE of 24 (borderline impaired), this aligns with early cognitive decline.  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI)** (likely due to Alzheimer’s pathology)  \n**Confidence:** **Medium** (would benefit from longitudinal cognitive testing to confirm progression).  \n\n*(Note: If functional impairment in daily activities were confirmed, this could meet criteria for dementia due to Alzheimer’s disease.)*",
  "timestamp": "2025-07-25T21:18:07.329901"
}